Multiple Digital Biomarkers for Optimization of IBD Care
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorImelda GI Clinical Research Center
About this trial
To develop digital biomarkers associated with disease activity of inflammatory bowel disease
Eligibility criteria
Qualifiers
Males or females aged > 18 years
Diagnosis of CD, UC or IBD-unspecified for at least 1 month
Treatment with conventional or advanced therapy for IBD at initiation of the study
The patient must have access to an email address
Disqualifiers
Planned extended (> 1 month) overseas travel during the study period of 12 months, if internet access would be impossible, inconvenient or unaffordable during this time
Previous colectomy
Inability to communicate well with investigators or unable to comply with the study requirements
Significant medical condition interfering with physiological measurements trough a wearable device (heart failure, pacemaker or defibrillator)
Trial design
Treatments tested in this trial
- monitoring of wearable data, shopping data, biomarkers and patient reported outcomes
Treatment groups
80 Participants
are divided into 1 treatment groupSponsors and collaborators
Imelda GI Clinical Research Center
Lead sponsor
Agentschap Innoveren & Ondernemen (VLAIO)
Collaborator
Source ClinicalTrials.gov